Details

Archived 43: Summary: First booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age recommendations: NACI statement August 19, 2022 - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 18, 2025 · edition #1
Timestamp: 2025-04-18T14:13:49.663Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-first-booster-dose-pfizer-biontech-comirnaty-covid-19-vaccine-children-5-11-years/summary-august-19-2022.html?wbdisable=true
Replay URL: https://replay.healtharchive.ca/job-1/20250418141349/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-first-booster-dose-pfizer-biontech-comirnaty-covid-19-vaccine-children-5-11-years/summary-august-19-2022.html?wbdisable=true#ha_snapshot=140687
ID: 140687
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots